(Q45746650)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Gruber A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Berlit J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Speth C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Lass-Flörl C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Kofler G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Borg-von Zepelin M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Dierich MP

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Würzner R

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

133-144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Oral candidiasis and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Flow cytometric assay for combined measurement of phagocytosis and intracellular killing of Candida albicans.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Human immunodeficiency virus type 1 gp41 binds to Candida albicans via complement C3-like regions

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

Fluorescence assay for the detection of adherent Candida yeasts to target cells in microtest plates

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2899%2980052-7

7 January 2021

10.1016/S0171-2985(99)80052-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10532286%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference